Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS

Ghost authorship haunts industry-funded clinical trials

Drug companies make big contributions to analysis in the trials they fund but can fail to report their contributions.
  1. Matthew Warren
    View author publications

    You can also search for this author in PubMed  Google Scholar

An analysis of industry-funded clinical trials has found that drug companies are often heavily involved in research — but are not always transparent about it.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

doi: https://doi.org/10.1038/d41586-018-06986-x

References

  1. Rasmussen, K., Bero, L., Redberg, R., Gøtzsche, P. C. & Lundh, A. Br. Med. J. 363, k3654 (2018).

    Article  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links